ID: ALA5283726

Max Phase: Preclinical

Molecular Formula: C24H27ClN6O2

Molecular Weight: 466.97

Representations

Canonical SMILES:  Cc1cc(OCc2nc(N)nc(NCC(C)c3cccc(Cl)c3)n2)cc(N2CCCC2=O)c1

Standard InChI:  InChI=1S/C24H27ClN6O2/c1-15-9-19(31-8-4-7-22(31)32)12-20(10-15)33-14-21-28-23(26)30-24(29-21)27-13-16(2)17-5-3-6-18(25)11-17/h3,5-6,9-12,16H,4,7-8,13-14H2,1-2H3,(H3,26,27,28,29,30)

Standard InChI Key:  GYGMJQHVRJYATM-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 466.97

Molecular Weight (Monoisotopic): 466.1884

AlogP: 4.34

#Rotatable Bonds: 8

Polar Surface Area: 106.26

Molecular Species: NEUTRAL

HBA: 7

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 8

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 5.18

CX LogP: 4.62

CX LogD: 4.62

Aromatic Rings: 3

Heavy Atoms: 33

QED Weighted: 0.51

Np Likeness Score: -1.68

References

1. Lückmann M, Shenol A, Nissen TAD, Petersen JE, Kouvchinov D, Schwartz TW, Frimurer TM..  (2022)  Optimization of First-in-Class Dual-Acting FFAR1/FFAR4 Allosteric Modulators with Novel Mode of Action.,  13  (12.0): [PMID:36518697] [10.1021/acsmedchemlett.2c00160]

Source

Source(1):

• Scientific Literature